Colorectal cancer (CRC) is a global health concern. It is the third most prevalent cancer and the second leading cause of cancer-related deaths worldwide (
1,
2). In 2020, the estimated global mortality rate for CRC was over 900,000 (
1). Research indicates a rising incidence of CRC internationally, particularly in developing countries (
3). In 2020, the estimated age-standardized incidence rate of CRC in Iran was 12.0 - 19.1 per 100,000 in both sexes (
2). Several studies have confirmed that CRC incidence in Iran has increased over recent decades. This trend is expected to continue, contributing to the rising burden of CRC due to the current high incidence and mortality rates (
4,
5).
Colorectal cancer occurrence is associated with both genetic and acquired (environmental) factors. While genetic factors have a significant impact, modifying environmental factors can be highly effective in prevention (
6). Modifiable risk factors for CRC include smoking, diet, obesity, low physical activity, night shifts, and alcohol consumption. Non-modifiable risk factors include age, male sex, personal or family history of CRC or polyps, race, high-risk genetic syndromes, and diseases such as diabetes and inflammatory bowel disease (IBD) (
7,
8).
Common signs and symptoms of CRC include abdominal pain, rectal bleeding, an abdominal mass, changes in bowel habits (such as diarrhea or constipation), iron deficiency anemia (IDA), and unexplained weight loss. Among these manifestations, rectal bleeding is associated with the highest odds ratio for CRC (
9,
10).
Screening can reduce the mortality rate and incidence of CRC by up to 60% when using methods such as colonoscopy and fecal occult blood testing (FOBT) (
11). Therefore, CRC is considered one of the most preventable cancers and can be detected early through routine screening (
12). The long development period from early stages, such as polyps, provides an opportunity to improve CRC prognosis (
13). Since a significant portion of CRC etiology is related to modifiable factors, primary prevention is crucial. Given that most CRC cases develop slowly and originate from precursor lesions like adenomatous polyps, secondary prevention through screening methods—including stool-based tests, non-invasive imaging, and endoscopic procedures—is vital for healthcare providers (
6). Many studies have identified the lack of advice from medical doctors and healthcare workers as a major barrier to CRC screening in Asian countries (
14-
17). It has been shown that Asian doctors provide less advice compared to their American counterparts (
18). However, even in developed countries, CRC screening performance is often inadequate (
19). Numerous studies have indicated that the absence of physicians' recommendations significantly impacts CRC screening rates in Iran (
20-
24). Most average-risk individuals in Iran are unaware of available CRC screening tests and do not receive screening advice or information about CRC risk factors from their physicians (
25). In a study conducted in western Iran, the general population considered the lack of physician advice to be the most significant health system-related barrier to CRC screening (
20). Additionally, previous research in Hamadan found that physician support, as a component of social support, was a significant predictor of CRC screening intention (P < 0.05) among average-risk patients (
26). Some studies have examined the relationship between physicians’ knowledge of CRC screening and their characteristics, such as age, gender, and post-graduation education (
16,
22). However, there is limited relevant data available in Iran. These findings underscore the critical need for further evaluation of Iranian physicians’ knowledge and attitudes toward CRC screening.
Given the critical impact of screening on CRC incidence, mortality, and prognosis, overcoming barriers to screening programs is essential. One of the most important factors for an effective screening program is physicians' knowledge.